NO20044117L - Kinolinderivater - Google Patents

Kinolinderivater

Info

Publication number
NO20044117L
NO20044117L NO20044117A NO20044117A NO20044117L NO 20044117 L NO20044117 L NO 20044117L NO 20044117 A NO20044117 A NO 20044117A NO 20044117 A NO20044117 A NO 20044117A NO 20044117 L NO20044117 L NO 20044117L
Authority
NO
Norway
Prior art keywords
quinoline
Prior art date
Application number
NO20044117A
Other languages
English (en)
Norwegian (no)
Inventor
Peter Gull
Esteban Pombo Villar
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20044117L publication Critical patent/NO20044117L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/10Ophthalmic agents for accommodation disorders, e.g. myopia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20044117A 2002-03-07 2004-09-28 Kinolinderivater NO20044117L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02005117 2002-03-07
EP02005115 2002-03-07
PCT/EP2003/002321 WO2003074511A1 (en) 2002-03-07 2003-03-06 Quinoline derivatives

Publications (1)

Publication Number Publication Date
NO20044117L true NO20044117L (no) 2004-09-28

Family

ID=27790094

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044117A NO20044117L (no) 2002-03-07 2004-09-28 Kinolinderivater

Country Status (28)

Country Link
US (2) US7399768B2 (pl)
EP (1) EP1480970B1 (pl)
JP (2) JP2005519117A (pl)
KR (1) KR101027977B1 (pl)
CN (2) CN1939915A (pl)
AR (1) AR038730A1 (pl)
AU (1) AU2003219023B2 (pl)
BR (1) BR0308201A (pl)
CA (2) CA2477720C (pl)
CO (1) CO5611196A2 (pl)
CY (1) CY1106409T1 (pl)
DE (1) DE60311233T2 (pl)
DK (1) DK1480970T3 (pl)
EC (1) ECSP045271A (pl)
EG (1) EG24415A (pl)
ES (1) ES2279100T3 (pl)
IL (1) IL163769A0 (pl)
MX (1) MXPA04008666A (pl)
MY (1) MY134325A (pl)
NO (1) NO20044117L (pl)
NZ (1) NZ534732A (pl)
PE (1) PE20030927A1 (pl)
PL (2) PL210336B1 (pl)
PT (1) PT1480970E (pl)
RU (1) RU2345991C2 (pl)
SI (1) SI1480970T1 (pl)
TW (1) TW200406401A (pl)
WO (1) WO2003074511A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60328732D1 (de) * 2002-03-07 2009-09-17 Novartis Ag Chinolinderivate und ihre Anwendung bei Glaukom und Kurzsichtigkeit
JP7320507B2 (ja) 2017-11-24 2023-08-03 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
CN113727712B (zh) 2019-05-21 2024-11-15 H.隆德贝克有限公司 用于治疗帕金森病的儿茶酚胺氨基甲酸酯前药
EP3972971A1 (en) 2019-05-21 2022-03-30 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's diseases
WO2020234274A1 (en) 2019-05-21 2020-11-26 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's disease
JP7562562B2 (ja) 2019-05-21 2024-10-07 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
PE20030240A1 (es) * 2001-07-09 2003-04-16 Novartis Ag DERIVADOS DE BENZO [g] QUINOLINA

Also Published As

Publication number Publication date
ECSP045271A (es) 2004-10-26
PL210336B1 (pl) 2012-01-31
US20050234085A1 (en) 2005-10-20
DE60311233D1 (de) 2007-03-08
PL215012B1 (pl) 2013-10-31
AR038730A1 (es) 2005-01-26
PE20030927A1 (es) 2003-12-26
TW200406401A (en) 2004-05-01
DK1480970T3 (da) 2007-03-05
US7399768B2 (en) 2008-07-15
JP2005519117A (ja) 2005-06-30
PL394208A1 (pl) 2011-08-16
CA2477720C (en) 2010-09-21
CN1639148A (zh) 2005-07-13
MY134325A (en) 2007-12-31
ES2279100T3 (es) 2007-08-16
PL370915A1 (pl) 2005-06-13
DE60311233T2 (de) 2007-11-15
CY1106409T1 (el) 2011-10-12
RU2004129767A (ru) 2005-06-27
PT1480970E (pt) 2007-03-30
EP1480970B1 (en) 2007-01-17
RU2345991C2 (ru) 2009-02-10
KR101027977B1 (ko) 2011-04-13
JP2010095550A (ja) 2010-04-30
IL163769A0 (en) 2005-12-18
MXPA04008666A (es) 2004-12-06
WO2003074511A1 (en) 2003-09-12
SI1480970T1 (sl) 2007-06-30
CN1939915A (zh) 2007-04-04
AU2003219023A1 (en) 2003-09-16
CA2477720A1 (en) 2003-09-12
CN1293070C (zh) 2007-01-03
CO5611196A2 (es) 2006-02-28
EG24415A (en) 2009-05-25
EP1480970A1 (en) 2004-12-01
KR20040089615A (ko) 2004-10-21
AU2003219023B2 (en) 2006-11-30
CA2706618A1 (en) 2003-09-12
BR0308201A (pt) 2005-01-04
US20080255176A1 (en) 2008-10-16
NZ534732A (en) 2006-05-26
HK1071364A1 (en) 2005-07-15

Similar Documents

Publication Publication Date Title
NO20042121D0 (no) Kinolinforbindelse
DE60323499D1 (de) Tastverhältnisschätzer
DE60328364D1 (de) Abdominalretraktor
DE50306589D1 (de) Wischblatt
DE50311715D1 (de) Weltzeituhr
DE60318186D1 (de) Wachsamkeitsriegel
FI20021184A0 (fi) Lignaanivalmisteita
EP1426750A4 (en) TORQUE DETECTION DEVICE
DE60335555D1 (de) Enstands
DE60231468D1 (de) Einachsgrubber
DE60331717D1 (de) Zündunterbrecherschaltkreis
DE60320809D1 (de) Klemmring
DE60311233D1 (de) Chinolinderivate
EP1500402A4 (en) INHIBITOR OF CELL DEATH
ATE469773T1 (de) Zugöse
DE50305973D1 (de) Auffangwanne
DE50307628D1 (de) Getraenkehalter
DE60233684D1 (de) Dampfphasenepitaxiebauelement
DE60320010D1 (de) Endgeraetevorrichtung
DE50300322D1 (de) Zylinderkopfdichtung
NO20052727D0 (no) Tetrahydrokinolinderivater
NO20043433L (no) Fremgangsmate
FR2825344B1 (fr) Etiqueteuse
ATA15092002A (de) Beckenräumer
IS7870A (is) Tetrahýdrókínólín afleiður

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application